ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

White House Expected To Nominate Nobel Laureate Harold Varmus As NCI Director

March 17, 2010

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

Study Explores Reasons Women Avoid Mammograms

February 25, 2011

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999